Business News

Newport Corporation Reports Second Quarter 2008 Results

2008-07-30 15:05:00

Newport Corporation Reports Second Quarter 2008 Results

    IRVINE, Calif., July 30 /EMWNews/ -- Newport Corporation

(Nasdaq: NEWP) today reported financial results for its second quarter

ended June 28, 2008, and provided guidance regarding its outlook in the

third quarter of 2008.



    Sales in the second quarter of 2008 totaled $117.7 million, an increase

of 6.1% compared with the $110.9 million recorded in the second quarter of

2007. Sales in the first half of 2008 totaled $232.9 million, an increase

of 6.8% compared with the $218.2 million recorded in the first half of

2007. New orders received in the second quarter of 2008 totaled $110.1

million, a decrease of approximately 1.6% compared with the $111.9 million

recorded in the second quarter of 2007. New orders received in the first

half of 2008 totaled $235.1 million, an increase of 5.8% compared with the

$222.2 million recorded in the first half of 2007.



    Robert J. Phillippy, president and chief executive officer, commented,

"Despite weak overall macroeconomic conditions, we achieved our sales

objectives in the second quarter. In particular, we experienced strong

year-over-year increases in shipments of products to customers for

industrial manufacturing and photovoltaic applications. The strength in

these areas was offset in part by lower sales to research customers and

semiconductor equipment manufacturers."



    Commenting on orders, Mr. Phillippy stated, "Our order level for the

second quarter of 2008 was slightly below the comparable quarter of 2007

and was below our expectations, due primarily to lower orders received from

customers in the life and health sciences (LHS) market. This decrease in

LHS market orders was offset in part by higher orders from photovoltaic

customers. Following two consecutive quarters of all-time record orders

from LHS customers, we believe that our lower orders from this market in

the second quarter primarily reflect the timing of our customers' needs.

However, a few of our original equipment manufacturer (OEM) customers in

this market have reported a modest slowdown in demand for their medical

laser systems for cosmetic procedures. On the other hand, we continue to be

pleased by the traction we are gaining in the photovoltaic market. Our new

orders from photovoltaic customers in the second quarter exceeded $6.5

million, the second highest quarterly level ever recorded by Newport from

this market after the all-time record level in the first quarter of this

year. In the first half of 2008, we have received new orders totaling

approximately $22 million from customers in the photovoltaic industry."



    Based on generally accepted accounting principles (GAAP), Newport

reported a net loss in the second quarter of 2008 of $2.8 million, or $0.08

per diluted share, compared with net income of $8.0 million, or $0.20 per

diluted share, in the second quarter of 2007. Included in the net loss is a

non-cash, pre-tax charge of $7.1 million to write-off a note receivable and

other amounts relating to a business that had been classified as a

discontinued operation and subsequently sold in 2005. The buyer of that

business has failed to make certain principal, interest and rent payments

due under its agreements with Newport. The company has a secured interest

in the assets of the business and has begun legal proceedings to recover

the amounts owed. Pursuant to GAAP, the note receivable and other amounts

have been fully written off in the second quarter, and in future periods,

any cash received by the company in satisfaction of these items will be

recorded as other income in the company's financial statements. Excluding

this charge, the company would have reported net income of $4.0 million, or

$0.11 per diluted share, in the second quarter of 2008. For the first half

of 2008, Newport reported net income of $0.9 million, or $0.03 per diluted

share, compared with $13.2 million, or $0.33 per diluted share, in the

first half of 2007. Excluding the write-off charge, Newport's net income

for the first half of 2008 would have been $7.7 million, or $0.21 per

diluted share. A table reconciling the company's net income (loss) and net

income (loss) per diluted share for the second quarter and first half of

2008 in accordance with GAAP and on a non-GAAP basis excluding the

write-off is included for reference herein.



    The company's gross profit for the second quarter of 2008 was $47.3

million, or 40.2% of net sales, compared with $49.1 million, or 44.2% of

net sales, for the second quarter of 2007. The company's gross profit for

the first half of 2008 was $93.4 million, or 40.1% of net sales, compared

with $95.7 million, or 43.9% of net sales, for the first half of 2007. The

decrease in gross profit in both periods of 2008 was due primarily to lower

gross margins in the company's Lasers Division, which incurred higher

manufacturing costs and experienced greater market pricing pressure

compared with the corresponding periods of 2007.



    Selling, general and administrative (SG&A) expenses for the second

quarter of 2008 were $30.1 million, or 25.6% of net sales, compared with

$28.8 million, or 26.0% of net sales, in the second quarter of 2007. SG&A

expenses for the first half of 2008 totaled $59.9 million, or 25.7% of net

sales, compared with $58.8 million, or 27.0% of net sales, in the first

half of 2007.



    Research and development (R&D) expenses for the second quarter of 2008

were $12.3 million, or 10.5% of net sales, compared with $10.9 million, or

9.8% of net sales, in the second quarter of 2007. R&D expenses for the

first half of 2008 totaled $23.8 million, or 10.2% of net sales, compared

with $21.5 million, or 9.8% of net sales, in the corresponding period of

2007. The increase in R&D expenses in the 2008 periods was due primarily to

higher expenses related to the development of products targeted at the

photovoltaic industry.



    The company's cash, cash equivalents and marketable securities at the

end of the second quarter of 2008 totaled $141.1 million, an increase of

$6.7 million during the quarter.



    Mr. Phillippy continued, "While our operational performance in the

second quarter exceeded our expectations slightly, the low order intake

levels during the quarter, the generally weak conditions in our primary end

markets and the slower than anticipated rebound in our Lasers Division's

financial performance cause us to be cautious about our outlook for the

third quarter and second half of 2008. We currently expect our consolidated

net sales in the third quarter to be approximately 5% to 10% lower than the

second quarter of 2008. We also expect this reduction in revenue to

negatively impact our expected profitability in the third quarter,

particularly in our Lasers Division. As a result of this weaker financial

outlook, we are in the process of analyzing and quantifying actions to

improve our financial performance in the second half of this year and in

2009. Once this analysis is completed, we will quantify the expected

financial impact in the third and fourth quarters of this year. In

addition, as we work through the legal process to recover the amounts owed

relating to the discontinued operation, we anticipate recovering some, if

not all, of the amounts that were written off. As these actions are

finalized and the legal proceedings progress and their financial impacts

are quantified, we will provide updated guidance."



    ABOUT NEWPORT CORPORATION



    Newport Corporation is a leading global supplier of advanced-technology

products and systems to customers in the scientific research,

microelectronics, aerospace and defense/security, life and health sciences

and precision industrial manufacturing markets. Newport's innovative

solutions leverage its expertise in high-power semiconductor, solid-state

and ultrafast lasers, photonics instrumentation, sub-micron positioning

systems, vibration isolation, optical components and subsystems and

precision automation to enhance the capabilities and productivity of its

customers' manufacturing, engineering and research applications. Newport is

part of the Standard & Poor's SmallCap 600 Index and the Russell 2000

Index.



    INVESTOR CONFERENCE CALL



    Robert J. Phillippy, president and chief executive officer, and Charles

F. Cargile, senior vice president, chief financial officer and treasurer,

will host an investor conference call today, July 30, 2008, at 5:00 p.m.

Eastern time (2:00 p.m. Pacific time) to review the company's results for

the second quarter of 2008 and its business outlook. The call will be open

to all interested investors through a live audio web broadcast via the

Internet at http://www.newport.com/investors and http://www.earnings.com. The call also

will be available to investors and analysts by dialing (888) 684-1262

within the U.S. and Canada or (913) 312-1495 from abroad.



    The webcast will be archived on both websites and can be reached

through the same links. A telephonic playback of the conference call also

will be available by calling (888) 203-1112 within the U.S. and Canada or

(719) 457-0820 from abroad. Playback will be available beginning at 8:00

p.m. Eastern time (5:00 p.m. Pacific time) on Wednesday, July 30, 2008, and

continue through 8:00 p.m. on Wednesday, August 6, 2008. The replay

confirmation code is 6469557.



    SAFE HARBOR STATEMENT



    This news release contains forward-looking statements, including

without limitation statements regarding Newport's expected sales and

profitability in the third quarter of 2008 and the actions being considered

to improve its financial results for the second half of 2008 and for 2009,

and Newport's anticipated recovery of amounts owed relating to the sale of

its previously discontinued operation. Without limiting the generality of

the foregoing, words such as "may," "will," "expect," "believe,"

"anticipate," "intend," "could," "estimate" or "continue" or the negative

or other variations thereof or comparable terminology are intended to

identify forward-looking statements. In addition, any statements that refer

to expectations, projections or other characterizations of future events or

circumstances are forward-looking statements. As discussed in Newport's

Annual Report on Form 10-K for the year ended December 29, 2007,

assumptions relating to the foregoing involve judgments and risks with

respect to, among other things, the outcome of legal proceedings relating

to the recovery of amounts due to Newport; the timing of acquisition and

divestiture activities and the amounts of charges associated with those

activities; the strength of business conditions in the industries Newport

serves, particularly the semiconductor industry; Newport's ability to

successfully penetrate and increase sales to its targeted end markets,

particularly to photovoltaic customers and the life and health sciences

market; Newport's ability to successfully integrate businesses acquired;

the levels of private and governmental research funding worldwide;

potential order cancellations and push-outs; potential product returns;

future economic, competitive and market conditions, including those in

Europe and Asia and those related to its strategic markets; whether its

products will continue to achieve customer acceptance; and future business

decisions, all of which are difficult or impossible to predict accurately

and many of which are beyond the control of Newport. Although Newport

believes that the assumptions underlying the forward-looking statements are

reasonable, any of the assumptions could prove inaccurate and, therefore,

there can be no assurance that the results contemplated in forward-looking

statements will be realized. In light of the significant uncertainties

inherent in the forward-looking information included herein, the inclusion

of such information should not be regarded as a representation by Newport

or any other person that Newport's objectives or plans will be achieved.

Newport undertakes no obligation to revise the forward-looking statements

contained herein to reflect events or circumstances after the date hereof

or to reflect the occurrence of unanticipated events.




Newport Corporation Consolidated Statements of Operations (Unaudited) Three Months Ended Six Months Ended June 28, June 30, June 28, June 30, (In thousands) 2008 2007 2008 2007 Net sales $117,664 $110,904 $232,907 $218,168 Cost of sales 70,367 61,843 139,499 122,476 Gross profit 47,297 49,061 93,408 95,692 Selling, general and administrative expenses 30,092 28,792 59,883 58,806 Research and development expense 12,341 10,874 23,785 21,477 Operating income 4,864 9,395 9,740 15,409 Write-down of note receivable and other amounts related to previously discontinued operations (7,060) - (7,060) - Interest and other income (expense), net (206) 16 (689) 217 Income before income taxes (2,402) 9,411 1,991 15,626 Income tax provision, net 390 1,448 1,058 2,412 Net income (loss) $(2,792) $7,963 $933 $13,214 Net income (loss) per share: Basic $(0.08) $0.20 $0.03 $0.33 Diluted $(0.08) $0.20 $0.03 $0.33 Shares used in the computation of net income (loss) per share: Basic 36,009 38,955 36,273 39,629 Diluted 36,009 39,554 36,385 40,491 Other operating data: New orders received during the period $110,076 $111,920 $235,051 $222,234 Backlog at the end of period scheduled to ship within 12 months $122,165 $111,913 Newport Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In thousands) Three Months Ended Six Months Ended June 28, June 30, June 28, June 30, 2008 2007 2008 2007 Net income (loss): Net income (loss) -- GAAP $(2,792) $7,963 $933 $13,214 Write-down of note receivable and other amounts related to previously discontinued operations, net of tax impact 6,759 - 6,759 - Non-GAAP net income $3,967 $7,963 $7,692 $13,214 Net income (loss) per diluted share: Net income (loss) -- GAAP $(0.08) $0.20 $0.03 $0.33 Write-down of note receivable and other amounts related to previously discontinued operations, net of tax impact 0.19 - 0.18 - Non-GAAP net income per diluted share $0.11 $0.20 $0.21 $0.33 Newport Corporation Consolidated Balance Sheets (Unaudited) June 28, December 29, (In thousands) 2008 2007 ASSETS Current assets: Cash and cash equivalents $65,142 $88,737 Marketable securities 75,982 55,127 Accounts receivable, net 90,095 87,606 Notes receivable, net 3,923 3,821 Inventories 112,820 113,969 Deferred income taxes 6,366 6,248 Prepaid expenses and other current assets 14,227 13,603 Total current assets 368,555 369,111 Property and equipment, net 65,266 61,872 Goodwill 174,197 174,197 Deferred income taxes 16,975 16,932 Intangible assets, net 44,131 46,171 Investments and other assets 16,362 21,664 $685,486 $689,947 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Short-term obligations $15,192 $12,402 Accounts payable 25,074 33,319 Accrued payroll and related expenses 22,520 23,096 Accrued expenses and other current liabilities 27,690 24,598 Total current liabilities 90,476 93,415 Long-term debt 175,000 175,000 Obligations under capital leases, less current portion 1,432 1,381 Accrued pension liabilities 11,510 10,740 Other liabilities 4,908 4,966 Stockholders' equity 402,160 404,445 $685,486 $689,947 Newport Corporation Sales & Orders by End Market (Unaudited) (In thousands, except percentages) Three Months Ended Six Months Ended 6/28/08 6/30/07 6/28/08 6/30/07 Sales by End Market Scientific research, aerospace and defense/security $38,015 $39,887 $76,452 $74,659 Microelectronics 36,594 32,963 72,894 64,733 Life and health sciences 20,941 20,124 41,708 40,850 Industrial manufacturing and other 22,114 17,930 41,853 37,926 Total $117,664 $110,904 $232,907 $218,168 As a percentage of net sales: Scientific research, aerospace and defense/security 32.3 36.0 32.8 34.2 Microelectronics 31.1 29.7 31.3 29.7 Life and health sciences 17.8 18.1 17.9 18.7 Industrial manufacturing and other 18.8 16.2 18.0 17.4 Total 100.0 100.0 100.0 100.0 Orders by End Market Scientific research, aerospace and defense/security $38,383 $40,601 $74,065 $76,314 Microelectronics 34,699 31,153 75,781 61,941 Life and health sciences 16,763 22,395 43,284 44,517 Industrial manufacturing and other 20,231 17,771 41,921 39,462 Total $110,076 $111,920 $235,051 $222,234 As a percentage of total orders: Scientific research, aerospace and defense/security 34.9 36.3 31.5 34.3 Microelectronics 31.5 27.8 32.3 27.9 Life and health sciences 15.2 20.0 18.4 20.0 Industrial manufacturing and other 18.4 15.9 17.8 17.8 Total 100.0 100.0 100.0 100.0 Note: Sales and orders from semiconductor equipment manufacturers and photovoltaic customers are included in the company's Microelectronics end market.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions





























Jerry Cruz

Tops SEO Expert, Social Media Influencer and Editor. Having published and edited more than 4700+ Articles in the last 6 years definately a PRO!

Related Articles

Back to top button